SAN CARLOS, Calif.--(BUSINESS WIRE)--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced today positive top-line ...
Analysis results highlight the efficacy of cough suppression therapy (CST) for those with chronic refractory cough and voice disorders. Results of a retrospective analysis show cough suppression ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it has begun dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results